Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf1
|
ENSMUSG00000054191.7 | Kruppel-like factor 1 (erythroid) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr8_84901875_84902316 | Klf1 | 167 | 0.856988 | 0.41 | 1.1e-03 | Click! |
chr8_84904304_84904574 | Klf1 | 2511 | 0.101167 | 0.31 | 1.6e-02 | Click! |
chr8_84900951_84901706 | Klf1 | 600 | 0.458896 | 0.31 | 1.6e-02 | Click! |
chr8_84902494_84903152 | Klf1 | 895 | 0.299977 | 0.27 | 3.5e-02 | Click! |
chr8_84905120_84905271 | Klf1 | 3267 | 0.084698 | 0.24 | 6.2e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_85686512_85689764 | 12.95 |
Six2 |
sine oculis-related homeobox 2 |
116 |
0.96 |
chr5_64810297_64813272 | 11.76 |
Klf3 |
Kruppel-like factor 3 (basic) |
555 |
0.71 |
chr2_25577192_25580600 | 11.04 |
Ajm1 |
apical junction component 1 |
1001 |
0.25 |
chr19_45230983_45235468 | 10.17 |
Lbx1 |
ladybird homeobox 1 |
2587 |
0.27 |
chr7_44350602_44354420 | 9.78 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
1749 |
0.15 |
chr6_83068298_83071797 | 9.78 |
Tlx2 |
T cell leukemia, homeobox 2 |
178 |
0.81 |
chr2_105125289_105128976 | 9.73 |
Wt1 |
Wilms tumor 1 homolog |
78 |
0.91 |
chr4_154635108_154637998 | 9.56 |
Prdm16 |
PR domain containing 16 |
244 |
0.83 |
chr11_96343236_96346574 | 9.41 |
Hoxb3 |
homeobox B3 |
1136 |
0.24 |
chr11_102145120_102148094 | 9.19 |
Nags |
N-acetylglutamate synthase |
241 |
0.58 |
chr11_85829139_85831432 | 8.91 |
2610027K06Rik |
RIKEN cDNA 2610027K06 gene |
1924 |
0.21 |
chr11_117779316_117780928 | 8.81 |
Tmc6 |
transmembrane channel-like gene family 6 |
472 |
0.61 |
chr9_107489458_107490875 | 8.80 |
Cacna2d2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
15438 |
0.08 |
chr2_9882196_9886301 | 8.36 |
9230102O04Rik |
RIKEN cDNA 9230102O04 gene |
255 |
0.84 |
chr9_98954965_98956948 | 8.35 |
Foxl2os |
forkhead box L2, opposite strand |
657 |
0.38 |
chr2_153528339_153529939 | 8.31 |
Nol4l |
nucleolar protein 4-like |
832 |
0.63 |
chr5_119673827_119675890 | 8.24 |
Tbx3 |
T-box 3 |
587 |
0.67 |
chrX_53055829_53057122 | 8.11 |
C430049B03Rik |
RIKEN cDNA C430049B03 gene |
685 |
0.41 |
chr2_146834060_146838027 | 8.04 |
Gm14114 |
predicted gene 14114 |
3689 |
0.27 |
chr12_33966605_33968831 | 7.94 |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
10047 |
0.22 |
chr3_129216664_129219042 | 7.93 |
Pitx2 |
paired-like homeodomain transcription factor 2 |
3578 |
0.2 |
chr5_28457868_28460972 | 7.90 |
9530036O11Rik |
RIKEN cDNA 9530036O11Rik |
1146 |
0.51 |
chr14_100284227_100286288 | 7.51 |
Klf12 |
Kruppel-like factor 12 |
578 |
0.59 |
chr3_84269309_84270900 | 7.13 |
Trim2 |
tripartite motif-containing 2 |
687 |
0.77 |
chrX_137118132_137120673 | 6.99 |
Esx1 |
extraembryonic, spermatogenesis, homeobox 1 |
769 |
0.36 |
chr6_52259871_52261414 | 6.98 |
Hoxa13 |
homeobox A13 |
160 |
0.84 |
chr11_104309715_104311017 | 6.98 |
Mapt |
microtubule-associated protein tau |
7667 |
0.17 |
chr12_95693703_95697493 | 6.95 |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
241 |
0.92 |
chr10_103027884_103029519 | 6.88 |
Alx1 |
ALX homeobox 1 |
74 |
0.97 |
chr4_44711553_44714511 | 6.87 |
Pax5 |
paired box 5 |
2545 |
0.22 |
chr7_142662290_142664788 | 6.72 |
Igf2os |
insulin-like growth factor 2, opposite strand |
1599 |
0.21 |
chr7_142654280_142656231 | 6.71 |
Mir483 |
microRNA 483 |
259 |
0.76 |
chr5_147304305_147307985 | 6.66 |
Cdx2 |
caudal type homeobox 2 |
1125 |
0.33 |
chr9_64671845_64672188 | 6.66 |
Megf11 |
multiple EGF-like-domains 11 |
11557 |
0.21 |
chr6_30172641_30174725 | 6.65 |
Rncr4 |
retina expressed non-coding RNA 4 |
790 |
0.51 |
chr7_5029343_5032174 | 6.64 |
Zfp865 |
zinc finger protein 865 |
1434 |
0.15 |
chr8_84722866_84724458 | 6.62 |
G430095P16Rik |
RIKEN cDNA G430095P16 gene |
655 |
0.54 |
chr8_70493071_70496051 | 6.62 |
Crlf1 |
cytokine receptor-like factor 1 |
1200 |
0.25 |
chr2_172549301_172551909 | 6.57 |
Tfap2c |
transcription factor AP-2, gamma |
48 |
0.98 |
chr11_98967692_98970737 | 6.55 |
Rara |
retinoic acid receptor, alpha |
8802 |
0.1 |
chr7_79841260_79842229 | 6.42 |
Anpep |
alanyl (membrane) aminopeptidase |
608 |
0.6 |
chr5_139550965_139553757 | 6.41 |
Uncx |
UNC homeobox |
8463 |
0.18 |
chr12_73052052_73054521 | 6.37 |
Six1 |
sine oculis-related homeobox 1 |
601 |
0.76 |
chr5_75148315_75152589 | 6.32 |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
1840 |
0.2 |
chr5_125386055_125387945 | 6.17 |
Ubc |
ubiquitin C |
2186 |
0.18 |
chr11_87756102_87757558 | 6.12 |
Mir142 |
microRNA 142 |
34 |
0.59 |
chr17_46073528_46074596 | 6.05 |
Gm36200 |
predicted gene, 36200 |
10204 |
0.13 |
chr6_23247289_23250418 | 6.03 |
Fezf1 |
Fez family zinc finger 1 |
491 |
0.76 |
chr8_57320946_57324000 | 5.98 |
Hand2os1 |
Hand2, opposite strand 1 |
1245 |
0.3 |
chr11_18870055_18872175 | 5.92 |
8430419K02Rik |
RIKEN cDNA 8430419K02 gene |
1040 |
0.49 |
chr3_96404203_96405307 | 5.92 |
Gm26654 |
predicted gene, 26654 |
2374 |
0.09 |
chr18_75384437_75388058 | 5.83 |
Smad7 |
SMAD family member 7 |
11333 |
0.21 |
chr12_73044500_73046647 | 5.82 |
Six1 |
sine oculis-related homeobox 1 |
282 |
0.92 |
chr7_142576289_142578620 | 5.81 |
H19 |
H19, imprinted maternally expressed transcript |
68 |
0.78 |
chr1_74949307_74952042 | 5.78 |
Ihh |
Indian hedgehog |
768 |
0.5 |
chr5_37826544_37829286 | 5.78 |
Msx1 |
msh homeobox 1 |
3332 |
0.25 |
chr11_83849571_83850989 | 5.77 |
Hnf1b |
HNF1 homeobox B |
217 |
0.83 |
chr11_94468500_94470223 | 5.73 |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
4280 |
0.16 |
chr13_60479224_60481361 | 5.71 |
Gm48500 |
predicted gene, 48500 |
1006 |
0.51 |
chr7_45797605_45798943 | 5.70 |
Lmtk3 |
lemur tyrosine kinase 3 |
10526 |
0.07 |
chr8_89044579_89046585 | 5.67 |
Sall1 |
spalt like transcription factor 1 |
1420 |
0.48 |
chr8_91800429_91802211 | 5.66 |
Irx3 |
Iroquois related homeobox 3 |
595 |
0.52 |
chr11_117790378_117791315 | 5.64 |
Tmc8 |
transmembrane channel-like gene family 8 |
342 |
0.52 |
chr19_25505518_25507191 | 5.64 |
Dmrt1 |
doublesex and mab-3 related transcription factor 1 |
647 |
0.72 |
chr3_96458110_96459469 | 5.61 |
Gm10685 |
predicted gene 10685 |
580 |
0.4 |
chr4_133057277_133058152 | 5.57 |
Ahdc1 |
AT hook, DNA binding motif, containing 1 |
8535 |
0.19 |
chr2_33639069_33641423 | 5.55 |
Lmx1b |
LIM homeobox transcription factor 1 beta |
234 |
0.85 |
chr18_12947287_12947788 | 5.54 |
Osbpl1a |
oxysterol binding protein-like 1A |
5696 |
0.19 |
chr6_30737706_30740349 | 5.48 |
Mest |
mesoderm specific transcript |
972 |
0.4 |
chr8_71665120_71666309 | 5.45 |
Unc13a |
unc-13 homolog A |
2368 |
0.14 |
chr2_174283563_174287177 | 5.44 |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
12 |
0.53 |
chr15_102998770_103001153 | 5.44 |
Hoxc6 |
homeobox C6 |
568 |
0.54 |
chr4_114901229_114903111 | 5.37 |
9130410C08Rik |
RIKEN cDNA 9130410C08 gene |
689 |
0.59 |
chr14_46385551_46387400 | 5.34 |
Bmp4 |
bone morphogenetic protein 4 |
829 |
0.41 |
chr8_84901875_84902316 | 5.30 |
Klf1 |
Kruppel-like factor 1 (erythroid) |
167 |
0.86 |
chr17_29963564_29965159 | 5.29 |
Mdga1 |
MAM domain containing glycosylphosphatidylinositol anchor 1 |
5726 |
0.14 |
chr8_92356309_92358734 | 5.27 |
Irx5 |
Iroquois homeobox 5 |
104 |
0.95 |
chr4_99650241_99651897 | 5.27 |
Gm12688 |
predicted gene 12688 |
3914 |
0.16 |
chr11_6412919_6413226 | 5.27 |
Ppia |
peptidylprolyl isomerase A |
2371 |
0.15 |
chr7_18949615_18951696 | 5.26 |
Nova2 |
NOVA alternative splicing regulator 2 |
24767 |
0.07 |
chr5_119669544_119672401 | 5.23 |
Tbx3 |
T-box 3 |
46 |
0.85 |
chr4_135152193_135153995 | 5.19 |
Runx3 |
runt related transcription factor 3 |
66 |
0.97 |
chr5_135041733_135042807 | 5.18 |
Stx1a |
syntaxin 1A (brain) |
1004 |
0.3 |
chr13_55835316_55837389 | 5.18 |
Pitx1 |
paired-like homeodomain transcription factor 1 |
160 |
0.62 |
chr10_80931763_80932916 | 5.14 |
Gadd45b |
growth arrest and DNA-damage-inducible 45 beta |
1527 |
0.22 |
chr15_99029361_99031026 | 5.12 |
Tuba1c |
tubulin, alpha 1C |
128 |
0.92 |
chr17_48300015_48301474 | 5.09 |
Treml2 |
triggering receptor expressed on myeloid cells-like 2 |
358 |
0.8 |
chr15_103013757_103015908 | 5.07 |
Mir615 |
microRNA 615 |
78 |
0.91 |
chr6_126163282_126164936 | 5.06 |
Ntf3 |
neurotrophin 3 |
851 |
0.73 |
chr5_120682337_120683693 | 5.01 |
Dtx1 |
deltex 1, E3 ubiquitin ligase |
100 |
0.93 |
chr12_112106418_112107477 | 4.95 |
Aspg |
asparaginase |
36 |
0.95 |
chr9_21337624_21338958 | 4.94 |
Slc44a2 |
solute carrier family 44, member 2 |
463 |
0.67 |
chr14_20793089_20794019 | 4.93 |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
412 |
0.6 |
chr11_77892631_77894065 | 4.89 |
Pipox |
pipecolic acid oxidase |
748 |
0.58 |
chr17_33917893_33918974 | 4.88 |
Tapbp |
TAP binding protein |
899 |
0.21 |
chr9_74865733_74868961 | 4.87 |
Onecut1 |
one cut domain, family member 1 |
863 |
0.54 |
chr8_121082801_121085531 | 4.87 |
Foxf1 |
forkhead box F1 |
220 |
0.71 |
chr17_46444584_46445824 | 4.85 |
Gm5093 |
predicted gene 5093 |
5107 |
0.11 |
chr17_84185673_84188034 | 4.77 |
Zfp36l2 |
zinc finger protein 36, C3H type-like 2 |
1094 |
0.34 |
chr6_84584705_84586412 | 4.76 |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
2122 |
0.4 |
chrX_12151122_12152833 | 4.76 |
Bcor |
BCL6 interacting corepressor |
8369 |
0.25 |
chr4_115057577_115059724 | 4.74 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
839 |
0.56 |
chr8_25542987_25545804 | 4.73 |
Gm16159 |
predicted gene 16159 |
9165 |
0.11 |
chr2_25290133_25293095 | 4.72 |
Grin1os |
glutamate receptor, ionotropic, NMDA1 (zeta 1), opposite strand |
394 |
0.57 |
chr1_130731543_130732516 | 4.71 |
AA986860 |
expressed sequence AA986860 |
53 |
0.94 |
chr10_103026340_103027824 | 4.71 |
Alx1 |
ALX homeobox 1 |
1545 |
0.39 |
chr16_94094122_94095708 | 4.68 |
Sim2 |
single-minded family bHLH transcription factor 2 |
9984 |
0.14 |
chr12_57534522_57535794 | 4.61 |
Gm37291 |
predicted gene, 37291 |
9432 |
0.15 |
chr14_25397115_25397717 | 4.61 |
Gm26660 |
predicted gene, 26660 |
17807 |
0.16 |
chr11_97439854_97442222 | 4.60 |
Arhgap23 |
Rho GTPase activating protein 23 |
4753 |
0.18 |
chr8_121124848_121126422 | 4.59 |
Foxl1 |
forkhead box L1 |
2305 |
0.19 |
chr17_56123820_56124985 | 4.58 |
Lrg1 |
leucine-rich alpha-2-glycoprotein 1 |
2401 |
0.13 |
chr13_56582551_56582734 | 4.58 |
2010203P06Rik |
RIKEN cDNA 2010203P06 gene |
12895 |
0.17 |
chr11_18873955_18876215 | 4.55 |
8430419K02Rik |
RIKEN cDNA 8430419K02 gene |
776 |
0.61 |
chr19_17355077_17356896 | 4.54 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
681 |
0.75 |
chr19_8989213_8990851 | 4.52 |
Ahnak |
AHNAK nucleoprotein (desmoyokin) |
737 |
0.46 |
chr4_136177602_136178758 | 4.52 |
E2f2 |
E2F transcription factor 2 |
2603 |
0.21 |
chr10_127339124_127340844 | 4.50 |
Gli1 |
GLI-Kruppel family member GLI1 |
25 |
0.94 |
chr11_89298118_89300658 | 4.48 |
Nog |
noggin |
2944 |
0.27 |
chr11_69399334_69402458 | 4.48 |
Kdm6bos |
KDM1 lysine (K)-specific demethylase 6B, opposite strand |
617 |
0.47 |
chr5_137485098_137486372 | 4.48 |
Epo |
erythropoietin |
81 |
0.93 |
chr19_5559639_5561263 | 4.47 |
1810058N15Rik |
RIKEN cDNA 1810058N15 gene |
191 |
0.47 |
chr18_75377002_75379136 | 4.47 |
Smad7 |
SMAD family member 7 |
3155 |
0.27 |
chr15_79440857_79442362 | 4.46 |
Csnk1e |
casein kinase 1, epsilon |
209 |
0.89 |
chr7_19022230_19023942 | 4.46 |
Foxa3 |
forkhead box A3 |
452 |
0.57 |
chr13_43261355_43261506 | 4.44 |
Gfod1 |
glucose-fructose oxidoreductase domain containing 1 |
41975 |
0.15 |
chr12_57538344_57540173 | 4.44 |
Foxa1 |
forkhead box A1 |
6863 |
0.16 |
chr7_142658126_142659753 | 4.44 |
Igf2 |
insulin-like growth factor 2 |
550 |
0.47 |
chr6_38342777_38343261 | 4.42 |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
11254 |
0.13 |
chr3_116860395_116860804 | 4.42 |
Frrs1 |
ferric-chelate reductase 1 |
1032 |
0.41 |
chr14_115040989_115042168 | 4.40 |
Mir17hg |
Mir17 host gene (non-protein coding) |
1301 |
0.2 |
chr5_114969022_114970855 | 4.38 |
Hnf1aos1 |
HNF1 homeobox A, opposite strand 1 |
18 |
0.91 |
chr5_112848482_112849121 | 4.38 |
Myo18b |
myosin XVIIIb |
22785 |
0.18 |
chr10_80834399_80836114 | 4.35 |
Mir1982 |
microRNA 1982 |
6459 |
0.07 |
chr2_74745819_74748448 | 4.35 |
Hoxd3 |
homeobox D3 |
1411 |
0.17 |
chr12_72939449_72940864 | 4.33 |
4930447C04Rik |
RIKEN cDNA 4930447C04 gene |
73 |
0.75 |
chr11_100144835_100146198 | 4.32 |
Krt19 |
keratin 19 |
604 |
0.52 |
chr13_55827549_55829422 | 4.31 |
Gm47071 |
predicted gene, 47071 |
2235 |
0.21 |
chr10_79735202_79736152 | 4.30 |
Polrmt |
polymerase (RNA) mitochondrial (DNA directed) |
1091 |
0.26 |
chr19_5842574_5845856 | 4.30 |
Neat1 |
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
1044 |
0.25 |
chr8_72642810_72643313 | 4.30 |
Nwd1 |
NACHT and WD repeat domain containing 1 |
3650 |
0.18 |
chr1_38128773_38130359 | 4.28 |
Rev1 |
REV1, DNA directed polymerase |
96 |
0.96 |
chr10_69910046_69911074 | 4.28 |
Ank3 |
ankyrin 3, epithelial |
4305 |
0.35 |
chr11_96282910_96285155 | 4.27 |
Hoxb8 |
homeobox B8 |
1307 |
0.19 |
chr18_64331856_64333830 | 4.26 |
St8sia3os |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3, opposite strand |
863 |
0.56 |
chr3_34648572_34651394 | 4.26 |
Sox2 |
SRY (sex determining region Y)-box 2 |
422 |
0.73 |
chr4_131920577_131922124 | 4.26 |
Tmem200b |
transmembrane protein 200B |
150 |
0.52 |
chr13_55825087_55826711 | 4.25 |
Gm47071 |
predicted gene, 47071 |
351 |
0.82 |
chr15_102027906_102029019 | 4.25 |
Krt18 |
keratin 18 |
282 |
0.85 |
chr7_100492685_100494805 | 4.24 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
50 |
0.95 |
chr2_71540308_71541815 | 4.24 |
Dlx1as |
distal-less homeobox 1, antisense |
3170 |
0.18 |
chr7_49634786_49637154 | 4.23 |
Dbx1 |
developing brain homeobox 1 |
879 |
0.68 |
chr14_54408224_54410842 | 4.22 |
Slc7a7 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 |
73 |
0.94 |
chr4_140813807_140815024 | 4.22 |
Gm13032 |
predicted gene 13032 |
3422 |
0.16 |
chr4_11385045_11386187 | 4.21 |
Esrp1 |
epithelial splicing regulatory protein 1 |
778 |
0.6 |
chr10_80018650_80020555 | 4.21 |
Arhgap45 |
Rho GTPase activating protein 45 |
51 |
0.93 |
chr1_4495967_4497921 | 4.19 |
Sox17 |
SRY (sex determining region Y)-box 17 |
187 |
0.71 |
chr19_5756395_5757941 | 4.19 |
Ltbp3 |
latent transforming growth factor beta binding protein 3 |
198 |
0.83 |
chr2_168765766_168766653 | 4.19 |
Gm14261 |
predicted gene 14261 |
66 |
0.94 |
chr1_135324343_135325907 | 4.19 |
Lmod1 |
leiomodin 1 (smooth muscle) |
318 |
0.83 |
chr16_5131498_5132854 | 4.18 |
Ppl |
periplakin |
234 |
0.89 |
chr7_45169391_45170216 | 4.16 |
Slc17a7 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 |
98 |
0.87 |
chr7_99594627_99596228 | 4.12 |
Arrb1 |
arrestin, beta 1 |
804 |
0.48 |
chr4_130252226_130252946 | 4.12 |
Serinc2 |
serine incorporator 2 |
22632 |
0.13 |
chr8_122546551_122549259 | 4.11 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3424 |
0.12 |
chr19_6263913_6264509 | 4.11 |
Mir194-2 |
microRNA 194-2 |
432 |
0.48 |
chr6_52174920_52176658 | 4.06 |
Hoxaas3 |
Hoxa cluster antisense RNA 3 |
554 |
0.41 |
chr2_19429906_19432521 | 4.04 |
Gm13344 |
predicted gene 13344 |
770 |
0.52 |
chr7_45832800_45834021 | 4.04 |
Gm45441 |
predicted gene 45441 |
456 |
0.59 |
chr11_96331807_96334248 | 4.04 |
Hoxb3 |
homeobox B3 |
4965 |
0.08 |
chr1_139465696_139465986 | 4.03 |
Aspm |
abnormal spindle microtubule assembly |
11022 |
0.17 |
chr6_127154014_127155635 | 4.03 |
Ccnd2 |
cyclin D2 |
2631 |
0.16 |
chr10_122985250_122986569 | 4.00 |
D630033A02Rik |
RIKEN cDNA D630033A02 gene |
78 |
0.65 |
chr10_61544232_61544740 | 4.00 |
Gm47594 |
predicted gene, 47594 |
26425 |
0.1 |
chr11_4573644_4574075 | 4.00 |
Gm11960 |
predicted gene 11960 |
10227 |
0.16 |
chr11_52282454_52283691 | 3.98 |
Tcf7 |
transcription factor 7, T cell specific |
259 |
0.89 |
chr1_193152798_193154089 | 3.98 |
Irf6 |
interferon regulatory factor 6 |
289 |
0.85 |
chr5_134867554_134868195 | 3.98 |
Tmem270 |
transmembrane protein 270 |
38859 |
0.08 |
chr5_119681870_119683681 | 3.98 |
Tbx3 |
T-box 3 |
2526 |
0.22 |
chr8_84706606_84708426 | 3.96 |
Nfix |
nuclear factor I/X |
200 |
0.88 |
chr14_66241488_66242199 | 3.96 |
Ptk2b |
PTK2 protein tyrosine kinase 2 beta |
28291 |
0.16 |
chr17_80801064_80802812 | 3.94 |
Map4k3 |
mitogen-activated protein kinase kinase kinase kinase 3 |
73453 |
0.09 |
chr17_47737108_47738630 | 3.92 |
Tfeb |
transcription factor EB |
59 |
0.95 |
chr5_92128804_92129324 | 3.89 |
Uso1 |
USO1 vesicle docking factor |
8874 |
0.12 |
chr12_3806578_3808221 | 3.88 |
Dnmt3a |
DNA methyltransferase 3A |
239 |
0.92 |
chr4_108217222_108218259 | 3.88 |
Zyg11a |
zyg-11 family member A, cell cycle regulator |
182 |
0.94 |
chr17_84180639_84182724 | 3.86 |
Gm36279 |
predicted gene, 36279 |
4075 |
0.18 |
chr6_52245764_52247193 | 3.85 |
Hoxa11os |
homeobox A11, opposite strand |
257 |
0.65 |
chr15_102981032_102982455 | 3.84 |
Hoxc9 |
homeobox C9 |
4711 |
0.09 |
chr6_52247829_52249819 | 3.83 |
Hoxa11os |
homeobox A11, opposite strand |
402 |
0.59 |
chr11_98581976_98582749 | 3.83 |
Ormdl3 |
ORM1-like 3 (S. cerevisiae) |
5006 |
0.11 |
chr10_44526709_44528700 | 3.82 |
Prdm1 |
PR domain containing 1, with ZNF domain |
797 |
0.61 |
chr8_84912623_84913887 | 3.82 |
Dnase2a |
deoxyribonuclease II alpha |
136 |
0.88 |
chr4_62479845_62481162 | 3.81 |
Bspry |
B-box and SPRY domain containing |
414 |
0.75 |
chr4_106804374_106805428 | 3.81 |
Acot11 |
acyl-CoA thioesterase 11 |
97 |
0.96 |
chr11_83852457_83853638 | 3.81 |
Hnf1b |
HNF1 homeobox B |
87 |
0.96 |
chr17_55999652_56000753 | 3.81 |
Stap2 |
signal transducing adaptor family member 2 |
1722 |
0.17 |
chr5_107724563_107727169 | 3.80 |
Gfi1 |
growth factor independent 1 transcription repressor |
61 |
0.88 |
chr1_91052629_91054398 | 3.79 |
Lrrfip1 |
leucine rich repeat (in FLII) interacting protein 1 |
6 |
0.98 |
chr15_73661933_73662835 | 3.78 |
1700010B13Rik |
RIKEN cDNA 1700010B13 gene |
16510 |
0.15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.8 | 17.6 | GO:0010159 | specification of organ position(GO:0010159) |
7.7 | 23.0 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
7.3 | 14.7 | GO:0072050 | S-shaped body morphogenesis(GO:0072050) |
7.3 | 21.8 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
4.6 | 18.2 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
4.5 | 13.4 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
4.2 | 12.5 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
3.7 | 11.1 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
3.4 | 10.2 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
3.4 | 10.1 | GO:0002930 | trabecular meshwork development(GO:0002930) |
3.2 | 9.5 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
3.1 | 12.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
3.1 | 9.3 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
2.9 | 14.4 | GO:0007494 | midgut development(GO:0007494) |
2.9 | 8.6 | GO:0061205 | paramesonephric duct development(GO:0061205) |
2.8 | 2.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
2.8 | 8.5 | GO:0007403 | glial cell fate determination(GO:0007403) |
2.7 | 8.2 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
2.7 | 8.1 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
2.6 | 7.9 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
2.6 | 5.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
2.6 | 15.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
2.5 | 2.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
2.5 | 10.0 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
2.5 | 2.5 | GO:0035799 | ureter maturation(GO:0035799) |
2.5 | 7.4 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
2.5 | 4.9 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
2.5 | 7.4 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
2.4 | 26.9 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
2.4 | 9.7 | GO:0021557 | oculomotor nerve development(GO:0021557) |
2.4 | 2.4 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
2.3 | 7.0 | GO:0021570 | rhombomere 4 development(GO:0021570) |
2.3 | 7.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.3 | 4.6 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
2.3 | 4.6 | GO:0070384 | Harderian gland development(GO:0070384) |
2.3 | 11.5 | GO:0060751 | branch elongation involved in mammary gland duct branching(GO:0060751) |
2.3 | 2.3 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
2.2 | 6.6 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
2.2 | 6.6 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
2.2 | 6.6 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
2.2 | 6.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
2.1 | 6.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
2.0 | 3.9 | GO:0060594 | mammary gland specification(GO:0060594) |
2.0 | 7.8 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
1.9 | 3.9 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
1.9 | 1.9 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
1.8 | 5.5 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
1.8 | 3.7 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
1.8 | 5.4 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
1.8 | 7.2 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
1.8 | 7.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.8 | 5.3 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
1.7 | 5.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.7 | 3.4 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
1.7 | 3.4 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
1.7 | 6.9 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.7 | 5.0 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
1.7 | 1.7 | GO:0060435 | bronchiole development(GO:0060435) |
1.7 | 5.0 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
1.6 | 11.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
1.6 | 3.3 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.6 | 6.4 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
1.6 | 1.6 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
1.6 | 4.8 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
1.6 | 3.2 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
1.6 | 4.8 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.6 | 4.7 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
1.6 | 1.6 | GO:0048880 | sensory system development(GO:0048880) |
1.6 | 1.6 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
1.5 | 7.7 | GO:1904970 | brush border assembly(GO:1904970) |
1.5 | 1.5 | GO:0061010 | gall bladder development(GO:0061010) |
1.5 | 6.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
1.5 | 4.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.5 | 1.5 | GO:0061046 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) |
1.5 | 4.4 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.5 | 4.4 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
1.5 | 8.7 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
1.4 | 2.9 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.4 | 7.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.4 | 4.2 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.4 | 4.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.4 | 5.6 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.4 | 4.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.4 | 9.7 | GO:0048664 | neuron fate determination(GO:0048664) |
1.4 | 9.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
1.4 | 4.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.3 | 1.3 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
1.3 | 6.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
1.3 | 5.3 | GO:0060037 | pharyngeal system development(GO:0060037) |
1.3 | 5.3 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
1.3 | 5.2 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
1.3 | 3.9 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
1.3 | 3.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.3 | 5.2 | GO:0036302 | atrioventricular canal development(GO:0036302) |
1.3 | 6.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.3 | 5.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.3 | 2.6 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.3 | 1.3 | GO:0060214 | endocardium formation(GO:0060214) |
1.3 | 5.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
1.3 | 11.5 | GO:0048484 | enteric nervous system development(GO:0048484) |
1.3 | 2.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.3 | 3.8 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.3 | 2.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.2 | 2.5 | GO:0021550 | medulla oblongata development(GO:0021550) |
1.2 | 5.0 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
1.2 | 5.0 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
1.2 | 7.3 | GO:0051639 | actin filament network formation(GO:0051639) |
1.2 | 7.3 | GO:0035878 | nail development(GO:0035878) |
1.2 | 3.7 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
1.2 | 4.9 | GO:0006742 | NADP catabolic process(GO:0006742) |
1.2 | 1.2 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) negative regulation of cytoplasmic translation(GO:2000766) |
1.2 | 3.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
1.2 | 14.6 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
1.2 | 1.2 | GO:0061183 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
1.2 | 7.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.2 | 3.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.2 | 1.2 | GO:0033058 | directional locomotion(GO:0033058) |
1.2 | 3.5 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.2 | 2.4 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
1.2 | 5.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
1.2 | 16.2 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
1.2 | 2.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.1 | 3.4 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
1.1 | 1.1 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
1.1 | 3.4 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
1.1 | 1.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
1.1 | 6.7 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
1.1 | 1.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
1.1 | 4.4 | GO:0014028 | notochord formation(GO:0014028) |
1.1 | 1.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
1.1 | 7.7 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
1.1 | 1.1 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.1 | 68.8 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
1.1 | 1.1 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
1.1 | 5.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.1 | 6.5 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
1.1 | 2.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
1.1 | 23.4 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
1.1 | 2.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.1 | 1.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.1 | 3.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.0 | 4.2 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
1.0 | 4.2 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
1.0 | 1.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.0 | 2.1 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
1.0 | 4.1 | GO:0033504 | floor plate development(GO:0033504) |
1.0 | 5.1 | GO:0018101 | protein citrullination(GO:0018101) |
1.0 | 5.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
1.0 | 3.0 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.0 | 4.0 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
1.0 | 3.9 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.0 | 3.0 | GO:0015889 | cobalamin transport(GO:0015889) |
1.0 | 2.9 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.0 | 2.9 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
1.0 | 3.9 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.0 | 2.9 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
1.0 | 5.8 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.9 | 1.9 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.9 | 4.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.9 | 0.9 | GO:0065001 | proximal/distal axis specification(GO:0009946) specification of axis polarity(GO:0065001) |
0.9 | 3.8 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.9 | 2.8 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.9 | 3.8 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.9 | 1.9 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.9 | 3.8 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.9 | 0.9 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.9 | 2.8 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.9 | 0.9 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.9 | 4.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.9 | 2.8 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.9 | 1.9 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.9 | 7.4 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.9 | 1.9 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.9 | 5.5 | GO:0044351 | macropinocytosis(GO:0044351) |
0.9 | 2.8 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.9 | 1.8 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.9 | 2.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.9 | 1.8 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.9 | 2.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.9 | 1.8 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.9 | 2.7 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.9 | 0.9 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.9 | 3.6 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.9 | 2.7 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.9 | 1.8 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.9 | 1.8 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
0.9 | 5.3 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.9 | 1.8 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.9 | 2.7 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.9 | 0.9 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.9 | 2.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.9 | 0.9 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.9 | 7.0 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.9 | 2.6 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.9 | 3.5 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.9 | 1.7 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.9 | 9.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.9 | 0.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.9 | 1.7 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.9 | 3.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.9 | 6.0 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.9 | 21.3 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.9 | 2.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.8 | 1.7 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.8 | 2.5 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.8 | 1.7 | GO:0001757 | somite specification(GO:0001757) |
0.8 | 2.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.8 | 3.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.8 | 0.8 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.8 | 0.8 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.8 | 0.8 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.8 | 6.6 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.8 | 3.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.8 | 3.3 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.8 | 0.8 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.8 | 3.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.8 | 6.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.8 | 8.2 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.8 | 2.4 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.8 | 2.4 | GO:0060897 | neural plate regionalization(GO:0060897) |
0.8 | 5.7 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.8 | 1.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.8 | 0.8 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.8 | 2.4 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.8 | 2.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.8 | 0.8 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.8 | 5.5 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.8 | 0.8 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.8 | 0.8 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
0.8 | 3.9 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.8 | 0.8 | GO:0001794 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.8 | 2.3 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.8 | 2.3 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.8 | 5.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.8 | 4.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.8 | 3.1 | GO:0031033 | myosin filament organization(GO:0031033) |
0.8 | 1.5 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.8 | 1.5 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
0.8 | 2.3 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.7 | 3.7 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.7 | 0.7 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.7 | 2.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.7 | 1.5 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.7 | 1.5 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.7 | 0.7 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.7 | 5.2 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.7 | 2.2 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.7 | 2.2 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.7 | 4.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.7 | 1.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.7 | 3.6 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.7 | 2.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.7 | 2.2 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.7 | 2.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.7 | 1.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.7 | 1.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.7 | 2.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.7 | 2.9 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.7 | 2.2 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.7 | 2.9 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.7 | 2.1 | GO:0070836 | caveola assembly(GO:0070836) |
0.7 | 4.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.7 | 2.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.7 | 2.8 | GO:0060022 | hard palate development(GO:0060022) |
0.7 | 5.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.7 | 4.9 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.7 | 2.1 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.7 | 1.4 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.7 | 2.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.7 | 4.8 | GO:0030540 | female genitalia development(GO:0030540) |
0.7 | 2.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.7 | 2.7 | GO:0001842 | neural fold formation(GO:0001842) |
0.7 | 2.1 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.7 | 2.1 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.7 | 4.8 | GO:0060056 | mammary gland involution(GO:0060056) |
0.7 | 1.4 | GO:0071865 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.7 | 1.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.7 | 2.0 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) |
0.7 | 3.4 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.7 | 0.7 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.7 | 1.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.7 | 2.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.7 | 1.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.7 | 2.0 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.7 | 0.7 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.7 | 1.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.7 | 1.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.7 | 2.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.7 | 2.7 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.7 | 2.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.7 | 2.0 | GO:0015744 | succinate transport(GO:0015744) |
0.7 | 2.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.7 | 0.7 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.7 | 2.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.7 | 1.3 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.7 | 0.7 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.7 | 0.7 | GO:0060896 | neural plate pattern specification(GO:0060896) |
0.7 | 0.7 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.7 | 4.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.7 | 0.7 | GO:0071332 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.7 | 2.0 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.7 | 1.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.7 | 2.6 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.7 | 1.3 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.7 | 3.3 | GO:0060613 | fat pad development(GO:0060613) |
0.7 | 1.3 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.7 | 2.6 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.7 | 2.0 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.7 | 5.9 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.6 | 2.5 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.6 | 3.8 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.6 | 10.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.6 | 4.4 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.6 | 0.6 | GO:0032375 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.6 | 1.9 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.6 | 2.5 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.6 | 1.9 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.6 | 3.8 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.6 | 4.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.6 | 1.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.6 | 1.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.6 | 1.2 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.6 | 0.6 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.6 | 1.8 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.6 | 3.7 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.6 | 2.4 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.6 | 2.4 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.6 | 0.6 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.6 | 4.3 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.6 | 2.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.6 | 1.8 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.6 | 3.0 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.6 | 3.6 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.6 | 1.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.6 | 0.6 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.6 | 1.8 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.6 | 0.6 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.6 | 3.6 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.6 | 1.8 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.6 | 1.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.6 | 1.8 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.6 | 1.8 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.6 | 1.2 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.6 | 1.2 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.6 | 1.8 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.6 | 1.2 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.6 | 1.8 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.6 | 2.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.6 | 1.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.6 | 0.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.6 | 5.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.6 | 2.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.6 | 1.7 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.6 | 0.6 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
0.6 | 1.7 | GO:1902415 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
0.6 | 2.3 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.6 | 5.7 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.6 | 1.1 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.6 | 0.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.6 | 0.6 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.6 | 1.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.6 | 2.2 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.6 | 1.7 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.6 | 2.2 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.6 | 1.7 | GO:0003383 | apical constriction(GO:0003383) |
0.6 | 2.8 | GO:0007379 | segment specification(GO:0007379) |
0.6 | 1.1 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.6 | 2.2 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.5 | 2.2 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) Schwann cell proliferation(GO:0014010) |
0.5 | 4.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.5 | 0.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.5 | 2.7 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.5 | 4.9 | GO:0010226 | response to lithium ion(GO:0010226) |
0.5 | 5.9 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.5 | 3.2 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.5 | 2.7 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.5 | 1.1 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.5 | 1.6 | GO:0060430 | lung saccule development(GO:0060430) |
0.5 | 1.6 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.5 | 1.6 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.5 | 1.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.5 | 1.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.5 | 2.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.5 | 1.1 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.5 | 1.6 | GO:0006562 | proline catabolic process(GO:0006562) |
0.5 | 1.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.5 | 5.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.5 | 7.5 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.5 | 0.5 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.5 | 0.5 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.5 | 2.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.5 | 2.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.5 | 2.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.5 | 1.1 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
0.5 | 0.5 | GO:0030903 | notochord development(GO:0030903) |
0.5 | 2.6 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.5 | 1.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.5 | 1.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.5 | 1.0 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.5 | 1.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.5 | 1.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.5 | 0.5 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.5 | 0.5 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.5 | 0.5 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.5 | 0.5 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.5 | 2.0 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.5 | 1.0 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.5 | 2.0 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.5 | 1.5 | GO:0061042 | vascular wound healing(GO:0061042) |
0.5 | 0.5 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.5 | 1.5 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.5 | 0.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.5 | 2.0 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.5 | 1.5 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.5 | 2.0 | GO:0032196 | transposition(GO:0032196) |
0.5 | 1.5 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.5 | 1.5 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.5 | 3.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.5 | 0.5 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.5 | 4.4 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.5 | 1.0 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.5 | 0.5 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.5 | 1.5 | GO:0009299 | mRNA transcription(GO:0009299) |
0.5 | 4.3 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.5 | 4.8 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.5 | 3.4 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.5 | 1.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.5 | 2.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.5 | 1.0 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.5 | 1.4 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.5 | 0.9 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.5 | 0.5 | GO:0046618 | drug export(GO:0046618) |
0.5 | 0.5 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.5 | 2.4 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.5 | 1.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.5 | 0.9 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.5 | 1.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.5 | 0.9 | GO:0021546 | rhombomere development(GO:0021546) |
0.5 | 4.1 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.5 | 1.8 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.5 | 2.7 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.5 | 2.7 | GO:0060713 | labyrinthine layer morphogenesis(GO:0060713) |
0.5 | 1.8 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.5 | 1.4 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.5 | 1.4 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.5 | 0.9 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.5 | 1.8 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.5 | 1.8 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.5 | 0.5 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.5 | 1.4 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.5 | 4.1 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.4 | 5.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 1.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.4 | 3.1 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.4 | 0.9 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.4 | 1.3 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.4 | 1.3 | GO:0035483 | gastric emptying(GO:0035483) |
0.4 | 1.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.4 | 2.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.4 | 1.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.4 | 0.9 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.4 | 0.9 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 1.3 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.4 | 0.9 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.4 | 0.4 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.4 | 0.9 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.4 | 1.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.4 | 1.7 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.4 | 1.7 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.4 | 2.6 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.4 | 0.9 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.4 | 0.4 | GO:0032782 | bile acid secretion(GO:0032782) |
0.4 | 1.7 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.4 | 2.1 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.4 | 2.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.4 | 0.8 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.4 | 1.3 | GO:0003309 | type B pancreatic cell differentiation(GO:0003309) |
0.4 | 1.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.4 | 0.8 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.4 | 1.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.4 | 2.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.4 | 0.4 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.4 | 0.8 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.4 | 1.2 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.4 | 2.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.4 | 5.8 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.4 | 1.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.4 | 4.5 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 1.6 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.4 | 0.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.4 | 2.0 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.4 | 2.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.4 | 1.2 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.4 | 0.8 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.4 | 0.8 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.4 | 1.2 | GO:0097709 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.4 | 6.4 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.4 | 0.4 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.4 | 0.4 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.4 | 2.0 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.4 | 3.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.4 | 0.8 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.4 | 2.8 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.4 | 1.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.4 | 4.4 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.4 | 0.4 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.4 | 3.6 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.4 | 0.8 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.4 | 1.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.4 | 0.4 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.4 | 0.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.4 | 4.6 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.4 | 1.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.4 | 3.8 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.4 | 3.4 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.4 | 1.5 | GO:0097421 | liver regeneration(GO:0097421) |
0.4 | 1.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 1.9 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.4 | 2.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.4 | 0.8 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.4 | 1.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.4 | 2.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.4 | 1.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.4 | 1.5 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.4 | 1.1 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.4 | 0.4 | GO:0036296 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) cellular response to hyperoxia(GO:0071455) |
0.4 | 1.1 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.4 | 3.8 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.4 | 0.7 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.4 | 2.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.4 | 2.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.4 | 1.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.4 | 1.8 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.4 | 1.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.4 | 1.8 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.4 | 1.8 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.4 | 0.7 | GO:0048143 | astrocyte activation(GO:0048143) |
0.4 | 1.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.4 | 2.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.4 | 3.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 1.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 2.5 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.4 | 0.4 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.4 | 1.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 0.4 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.4 | 1.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.4 | 1.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.4 | 1.8 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.4 | 0.7 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.4 | 0.4 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.4 | 0.7 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.3 | 2.4 | GO:0051026 | chiasma assembly(GO:0051026) |
0.3 | 0.3 | GO:0003266 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
0.3 | 0.3 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.3 | 1.0 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.3 | 1.4 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 1.7 | GO:0043584 | nose development(GO:0043584) |
0.3 | 2.8 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.3 | 2.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.3 | 1.4 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.3 | 1.0 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.3 | 1.4 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.3 | 2.1 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.3 | 1.7 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.3 | 0.3 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.3 | 0.7 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 2.7 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.3 | 0.7 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.3 | 0.3 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.3 | 1.7 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 0.7 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.3 | 1.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.3 | 0.7 | GO:0030240 | skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
0.3 | 1.4 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.3 | 0.7 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.3 | 0.3 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.3 | 0.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 1.4 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.3 | 1.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 3.0 | GO:0070269 | pyroptosis(GO:0070269) |
0.3 | 2.3 | GO:0046697 | decidualization(GO:0046697) |
0.3 | 2.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.3 | 0.3 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.3 | 1.0 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.3 | 0.3 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.3 | 3.6 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.3 | 1.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 0.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.3 | 1.0 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.3 | 0.3 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.3 | 1.6 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.3 | 1.6 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.3 | 0.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 1.0 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.3 | 0.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.3 | 0.3 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.3 | 1.9 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 1.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.3 | 1.0 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.3 | 2.3 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.3 | 0.6 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 0.6 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.3 | 1.3 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.3 | 0.6 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 2.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.3 | 0.3 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.3 | 0.9 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.3 | 5.9 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.3 | 6.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.3 | 4.0 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.3 | 1.2 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) |
0.3 | 0.9 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.3 | 1.5 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 2.2 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.3 | 0.6 | GO:0045080 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) positive regulation of chemokine biosynthetic process(GO:0045080) |
0.3 | 0.6 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.3 | 0.9 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.3 | 4.3 | GO:0048535 | lymph node development(GO:0048535) |
0.3 | 2.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.3 | 1.5 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.3 | 4.6 | GO:0034340 | response to type I interferon(GO:0034340) |
0.3 | 1.2 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.3 | 0.9 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.3 | 0.6 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.3 | 0.6 | GO:0071354 | response to interleukin-6(GO:0070741) cellular response to interleukin-6(GO:0071354) |
0.3 | 3.3 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.3 | 0.3 | GO:2000380 | regulation of mesoderm development(GO:2000380) |
0.3 | 1.2 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.3 | 1.8 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.3 | 0.9 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 10.1 | GO:0035113 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
0.3 | 0.9 | GO:0009629 | response to gravity(GO:0009629) |
0.3 | 0.6 | GO:0035973 | aggrephagy(GO:0035973) |
0.3 | 0.9 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.3 | 0.6 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.3 | 0.3 | GO:0090267 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.3 | 1.5 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.3 | 0.9 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.3 | 2.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.3 | 14.2 | GO:0001890 | placenta development(GO:0001890) |
0.3 | 2.0 | GO:0046851 | negative regulation of bone remodeling(GO:0046851) |
0.3 | 3.2 | GO:0015858 | nucleoside transport(GO:0015858) |
0.3 | 0.6 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.3 | 0.9 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 2.9 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.3 | 2.0 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.3 | 0.6 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.3 | 0.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.3 | 0.6 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) negative regulation of bone development(GO:1903011) |
0.3 | 0.3 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.3 | 0.9 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.3 | 1.7 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 0.8 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.3 | 0.8 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.3 | 0.6 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.3 | 0.8 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.3 | 0.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.3 | 0.6 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 3.9 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.3 | 2.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 1.4 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.3 | 1.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 1.7 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.3 | 0.6 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.3 | 1.1 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.3 | 0.5 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.3 | 7.0 | GO:0031424 | keratinization(GO:0031424) |
0.3 | 1.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 0.3 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.3 | 3.8 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.3 | 0.8 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 0.8 | GO:1901679 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.3 | 1.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.3 | 0.8 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.3 | 1.1 | GO:0070970 | interleukin-2 secretion(GO:0070970) regulation of interleukin-2 secretion(GO:1900040) |
0.3 | 1.8 | GO:0046688 | response to copper ion(GO:0046688) |
0.3 | 0.5 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.3 | 0.8 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.3 | 2.3 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.3 | 2.0 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.3 | 0.8 | GO:0032353 | negative regulation of hormone biosynthetic process(GO:0032353) |
0.3 | 1.3 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.3 | 0.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.3 | 1.8 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 0.3 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.3 | 0.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.3 | 0.5 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) |
0.3 | 0.8 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 0.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.2 | 0.5 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.2 | 0.7 | GO:0018158 | protein oxidation(GO:0018158) |
0.2 | 3.0 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.2 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.2 | 0.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 2.5 | GO:0018904 | ether metabolic process(GO:0018904) |
0.2 | 0.7 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.2 | 0.5 | GO:0046909 | intermembrane transport(GO:0046909) |
0.2 | 0.7 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 0.2 | GO:0034165 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.2 | 1.7 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.2 | 8.0 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 3.4 | GO:0046677 | response to antibiotic(GO:0046677) |
0.2 | 0.2 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.2 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.2 | 0.2 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.2 | 1.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 1.7 | GO:0032329 | serine transport(GO:0032329) |
0.2 | 0.2 | GO:0044531 | negative regulation by symbiont of host apoptotic process(GO:0033668) modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) negative regulation by symbiont of host programmed cell death(GO:0052041) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.2 | 0.5 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 1.7 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.2 | GO:0042637 | catagen(GO:0042637) |
0.2 | 2.8 | GO:0042730 | fibrinolysis(GO:0042730) |
0.2 | 0.7 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 0.2 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 1.2 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 0.9 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.5 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.2 | 1.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 0.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 1.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 0.7 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.2 | 0.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 1.2 | GO:0033574 | response to testosterone(GO:0033574) |
0.2 | 0.7 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 0.7 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.2 | 0.5 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.2 | 0.5 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 0.5 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.2 | 1.4 | GO:1904385 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.2 | 0.9 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.2 | 1.8 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.2 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.2 | 0.9 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.2 | 1.4 | GO:1900364 | regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.2 | 0.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 0.4 | GO:0000087 | mitotic M phase(GO:0000087) |
0.2 | 0.2 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.2 | 1.1 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.4 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.4 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.2 | 1.8 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.2 | 0.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 2.2 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.2 | 3.2 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 0.6 | GO:1903798 | regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
0.2 | 0.9 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 5.4 | GO:0007498 | mesoderm development(GO:0007498) |
0.2 | 1.1 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.2 | 1.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.2 | 0.4 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 0.4 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.2 | 0.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.2 | 2.7 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 0.6 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 0.6 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 0.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 1.9 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.2 | 0.2 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.2 | 0.4 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.2 | 0.2 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.2 | 0.2 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.2 | 0.2 | GO:2000136 | regulation of cell proliferation involved in heart morphogenesis(GO:2000136) |
0.2 | 0.4 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.2 | 0.8 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.2 | 0.2 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.2 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.2 | 1.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.6 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 0.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 2.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.4 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.2 | 0.2 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.2 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.4 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.2 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 1.8 | GO:0050892 | intestinal absorption(GO:0050892) |
0.2 | 0.4 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.2 | 0.4 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.2 | 0.2 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.2 | 1.0 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.2 | 0.4 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.2 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 0.6 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 1.2 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.2 | 3.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 0.4 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.2 | 1.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 0.6 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 0.6 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 0.2 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.2 | 0.2 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.2 | 1.4 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 2.5 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.2 | 0.4 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 1.5 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 0.2 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.2 | 0.2 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.2 | 0.4 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 0.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 1.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 1.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 2.4 | GO:0048286 | lung alveolus development(GO:0048286) |
0.2 | 0.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.2 | 0.4 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.2 | 1.3 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.2 | 1.5 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.2 | 0.7 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 0.6 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.2 | 0.5 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 0.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 0.4 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.2 | 0.2 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.2 | 0.2 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.2 | 0.5 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.2 | 0.2 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.2 | 0.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.2 | 0.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 2.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 0.2 | GO:0002677 | microglial cell activation involved in immune response(GO:0002282) negative regulation of chronic inflammatory response(GO:0002677) |
0.2 | 0.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.2 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.2 | 1.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 1.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.2 | 0.5 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.2 | 1.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 0.9 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 0.5 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 0.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 0.2 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.2 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.7 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 0.7 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.2 | 0.5 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.2 | 0.7 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 0.9 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 1.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 0.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 0.5 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.2 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.2 | 0.3 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.2 | 1.2 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.2 | 0.2 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.2 | 0.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 0.5 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.5 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.2 | 0.5 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 0.8 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.2 | 1.5 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 0.2 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.2 | 0.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 0.5 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 0.3 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.2 | 1.0 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.2 | 0.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.2 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 1.1 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 0.3 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.2 | 0.6 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.2 | 1.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.8 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.2 | 0.3 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.2 | 0.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 0.3 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.2 | 0.3 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.2 | 0.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 0.2 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.2 | 1.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 0.2 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.2 | 0.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 0.9 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 0.8 | GO:0002076 | osteoblast development(GO:0002076) |
0.2 | 1.1 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 0.9 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.2 | 0.8 | GO:0033572 | transferrin transport(GO:0033572) |
0.2 | 0.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 0.5 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.2 | 0.5 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.2 | 0.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.2 | 0.9 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.2 | 0.3 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 0.6 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.4 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.1 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.1 | 0.6 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.7 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.3 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 1.5 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.1 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 0.9 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.1 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 1.7 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.4 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 0.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 1.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 2.5 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.4 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.3 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.3 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.1 | 0.4 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.4 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.7 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.5 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 2.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 1.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.1 | 0.1 | GO:0001839 | neural plate morphogenesis(GO:0001839) |
0.1 | 0.3 | GO:0072376 | protein activation cascade(GO:0072376) |
0.1 | 0.4 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.1 | 0.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.4 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.1 | 1.4 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 0.1 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 0.1 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 0.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 1.0 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.3 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.1 | 0.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.1 | 0.1 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.1 | 0.1 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) |
0.1 | 0.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.4 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.1 | 0.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.9 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.2 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.1 | 0.1 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.1 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.6 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 1.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.1 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 0.8 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 0.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.1 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.1 | 0.5 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.6 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.1 | 0.3 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 4.5 | GO:0006956 | complement activation(GO:0006956) |
0.1 | 0.5 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.1 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.1 | 1.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.3 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 1.2 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 1.8 | GO:0043297 | apical junction assembly(GO:0043297) |
0.1 | 0.2 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.5 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.1 | 0.2 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.1 | 8.3 | GO:0050657 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
0.1 | 0.1 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.1 | 1.6 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.4 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.1 | GO:0014732 | skeletal muscle atrophy(GO:0014732) striated muscle atrophy(GO:0014891) |
0.1 | 0.3 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.1 | 0.1 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.1 | 0.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.6 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.1 | 3.3 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.6 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.3 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.4 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.5 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.2 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.3 | GO:0006971 | hypotonic response(GO:0006971) |
0.1 | 1.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.5 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.5 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.2 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.1 | 0.4 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.8 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 2.3 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 1.7 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.1 | 0.3 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 0.4 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 1.6 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.1 | 0.8 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.1 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.1 | GO:0060571 | morphogenesis of an epithelial fold(GO:0060571) |
0.1 | 0.1 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.1 | 0.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 1.7 | GO:0048747 | muscle fiber development(GO:0048747) |
0.1 | 0.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.3 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.1 | 0.6 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.5 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.1 | 0.6 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.1 | 0.6 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 0.7 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 0.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.1 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.1 | 0.1 | GO:0019230 | proprioception(GO:0019230) |
0.1 | 0.3 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.1 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.6 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.1 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.1 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.5 | GO:0048536 | spleen development(GO:0048536) |
0.1 | 0.8 | GO:0030104 | water homeostasis(GO:0030104) |
0.1 | 0.5 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.2 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.1 | 0.1 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.1 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.1 | 0.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.2 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 1.5 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 1.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.1 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.2 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.1 | 0.1 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.1 | 0.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.3 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.1 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.1 | 0.2 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.7 | GO:0003229 | ventricular cardiac muscle tissue development(GO:0003229) |
0.1 | 0.8 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 2.1 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.1 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 0.2 | GO:0060968 | regulation of gene silencing(GO:0060968) |
0.1 | 0.8 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.2 | GO:0070255 | mucus secretion(GO:0070254) regulation of mucus secretion(GO:0070255) |
0.1 | 0.1 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.1 | 0.2 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.9 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 0.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.1 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.1 | 0.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.4 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.1 | 0.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.6 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.1 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.1 | 0.1 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 0.1 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.1 | 0.4 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.2 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.1 | 5.2 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.1 | 0.1 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 0.2 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 0.2 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.1 | 0.2 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.1 | GO:0043369 | alpha-beta T cell lineage commitment(GO:0002363) CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
0.1 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.1 | GO:1902583 | intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
0.1 | 0.2 | GO:0042533 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.1 | 0.2 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.4 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.2 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.0 | 0.0 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.0 | 0.3 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.2 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.5 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.0 | GO:0010224 | response to UV-B(GO:0010224) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.1 | GO:0072678 | T cell migration(GO:0072678) |
0.0 | 0.1 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 0.4 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.4 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.0 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.0 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.2 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.1 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
0.0 | 0.1 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.0 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.0 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.0 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.0 | 0.0 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.0 | 0.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.8 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.2 | GO:0070633 | transepithelial transport(GO:0070633) |
0.0 | 0.0 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.0 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.0 | 0.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.1 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.3 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.0 | 0.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.2 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.0 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.0 | 0.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.1 | GO:0042044 | fluid transport(GO:0042044) |
0.0 | 0.1 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.0 | 0.1 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.0 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.0 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.0 | 0.1 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.1 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.0 | GO:0039531 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039531) |
0.0 | 0.0 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.0 | 0.9 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.1 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.0 | 0.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0071359 | cellular response to dsRNA(GO:0071359) |
0.0 | 0.0 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.0 | 0.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.0 | 0.0 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.0 | 0.2 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.2 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.0 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.0 | 0.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.0 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.0 | 0.3 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.9 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
2.0 | 6.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.6 | 9.7 | GO:0031983 | vesicle lumen(GO:0031983) |
1.5 | 4.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
1.4 | 1.4 | GO:0005686 | U2 snRNP(GO:0005686) |
1.3 | 1.3 | GO:0031523 | Myb complex(GO:0031523) |
1.3 | 6.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.1 | 4.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.1 | 1.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.1 | 3.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.0 | 4.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
1.0 | 5.0 | GO:0008091 | spectrin(GO:0008091) |
0.9 | 3.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.9 | 6.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.9 | 5.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.9 | 3.5 | GO:0097452 | GAIT complex(GO:0097452) |
0.9 | 7.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.8 | 2.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.8 | 2.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.8 | 1.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.8 | 7.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.8 | 8.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.8 | 2.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.8 | 4.0 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.8 | 4.7 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.8 | 5.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.8 | 6.2 | GO:0005861 | troponin complex(GO:0005861) |
0.8 | 3.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.8 | 259.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.8 | 4.5 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.7 | 0.7 | GO:0044393 | microspike(GO:0044393) |
0.7 | 8.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.7 | 2.9 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.7 | 3.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.7 | 3.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.7 | 5.6 | GO:0036157 | outer dynein arm(GO:0036157) |
0.7 | 2.8 | GO:0099738 | cell cortex region(GO:0099738) |
0.7 | 4.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.7 | 2.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.7 | 1.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.7 | 2.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.7 | 9.8 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.7 | 1.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.6 | 2.6 | GO:1990357 | terminal web(GO:1990357) |
0.6 | 1.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.6 | 1.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.6 | 7.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.6 | 1.9 | GO:0005688 | U6 snRNP(GO:0005688) |
0.6 | 2.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.6 | 2.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.6 | 3.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.6 | 2.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.6 | 8.2 | GO:0031430 | M band(GO:0031430) |
0.6 | 2.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.6 | 1.7 | GO:1990393 | 3M complex(GO:1990393) |
0.6 | 3.4 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.6 | 5.7 | GO:0032426 | stereocilium tip(GO:0032426) |
0.6 | 1.7 | GO:0048179 | activin receptor complex(GO:0048179) |
0.6 | 4.5 | GO:0001650 | fibrillar center(GO:0001650) |
0.5 | 1.6 | GO:0005914 | spot adherens junction(GO:0005914) |
0.5 | 2.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.5 | 27.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.5 | 2.0 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.5 | 3.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.5 | 0.5 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.5 | 2.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.5 | 5.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.5 | 2.5 | GO:0005638 | lamin filament(GO:0005638) |
0.5 | 1.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.5 | 1.4 | GO:0000811 | GINS complex(GO:0000811) |
0.5 | 2.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.5 | 1.9 | GO:0033269 | internode region of axon(GO:0033269) |
0.5 | 1.4 | GO:0070552 | BRISC complex(GO:0070552) |
0.5 | 0.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.5 | 2.8 | GO:0097342 | ripoptosome(GO:0097342) |
0.5 | 0.9 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 4.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.4 | 4.0 | GO:0036128 | CatSper complex(GO:0036128) |
0.4 | 1.8 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.4 | 0.4 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.4 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.4 | 3.4 | GO:0000243 | commitment complex(GO:0000243) |
0.4 | 2.5 | GO:0000812 | Swr1 complex(GO:0000812) |
0.4 | 9.4 | GO:0008305 | integrin complex(GO:0008305) |
0.4 | 2.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.4 | 1.9 | GO:0044194 | cytolytic granule(GO:0044194) |
0.4 | 1.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.4 | 0.4 | GO:0043219 | lateral loop(GO:0043219) |
0.4 | 1.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.4 | 1.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.4 | 1.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.4 | 10.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 7.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 2.5 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.4 | 1.4 | GO:0042825 | TAP complex(GO:0042825) |
0.4 | 3.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.4 | 15.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.4 | 10.2 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.3 | 1.7 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 1.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 0.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 0.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 1.3 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 5.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 18.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 0.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 0.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 7.0 | GO:0051233 | spindle midzone(GO:0051233) |
0.3 | 12.9 | GO:0045095 | keratin filament(GO:0045095) |
0.3 | 5.7 | GO:0031672 | A band(GO:0031672) |
0.3 | 0.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.3 | 0.9 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 3.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.3 | 1.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 3.7 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 2.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.3 | 0.9 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 0.6 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 2.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.3 | 1.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.3 | 11.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 1.8 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 0.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 0.9 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 1.1 | GO:0000938 | GARP complex(GO:0000938) |
0.3 | 0.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 0.8 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 0.8 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.3 | 3.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 1.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 2.2 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 0.3 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.3 | 2.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 2.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 1.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 3.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 1.6 | GO:0042627 | chylomicron(GO:0042627) |
0.3 | 8.2 | GO:0005844 | polysome(GO:0005844) |
0.3 | 1.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 4.7 | GO:0043073 | male germ cell nucleus(GO:0001673) germ cell nucleus(GO:0043073) |
0.2 | 2.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 3.2 | GO:0038201 | TOR complex(GO:0038201) |
0.2 | 21.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 2.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 0.7 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 0.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 2.1 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 0.7 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 0.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 0.7 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 0.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 2.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 2.5 | GO:0002102 | podosome(GO:0002102) |
0.2 | 1.1 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 0.9 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.2 | 1.8 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.9 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 0.6 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 0.9 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 0.8 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 3.3 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 1.8 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 0.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 0.8 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 0.6 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 0.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 0.4 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 0.6 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 1.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 3.3 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 4.9 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 1.8 | GO:0032797 | SMN complex(GO:0032797) |
0.2 | 0.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 0.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 0.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 2.1 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 0.9 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 1.7 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.9 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 2.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 0.5 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 3.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 1.4 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 0.7 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 0.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 0.5 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 0.5 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 5.6 | GO:0030118 | clathrin coat(GO:0030118) |
0.2 | 0.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 0.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 3.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 0.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 9.3 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.2 | 3.4 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 2.7 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 3.1 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 0.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.9 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 1.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 1.0 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 3.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.3 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 7.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.6 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 1.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 1.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 4.1 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 1.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 1.0 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 11.0 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 6.7 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 0.3 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 1.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 2.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 6.3 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 1.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.5 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.6 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 14.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.1 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.1 | 0.4 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.3 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 0.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 1.0 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 4.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 1.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.2 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.1 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 9.0 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 1.8 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 2.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 21.5 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.5 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.8 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 1.9 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 6.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.2 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 3.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.9 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.6 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 5.3 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 3.8 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 43.0 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.8 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 22.4 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.0 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.0 | 0.5 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
2.4 | 14.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
2.3 | 30.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
2.3 | 6.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.2 | 6.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.9 | 5.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.7 | 5.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.7 | 9.9 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.6 | 4.8 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.5 | 4.5 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.5 | 4.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.4 | 1.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.4 | 5.7 | GO:0034618 | arginine binding(GO:0034618) |
1.4 | 4.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.3 | 6.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
1.2 | 5.0 | GO:0009374 | biotin binding(GO:0009374) |
1.2 | 3.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.2 | 3.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
1.2 | 1.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.2 | 67.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
1.1 | 5.7 | GO:0005499 | vitamin D binding(GO:0005499) |
1.1 | 2.3 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.1 | 3.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.1 | 3.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.1 | 22.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.1 | 3.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.1 | 3.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.1 | 8.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.1 | 4.4 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.1 | 4.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
1.1 | 4.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.0 | 3.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.0 | 32.4 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
1.0 | 8.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
1.0 | 6.2 | GO:0001164 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
1.0 | 9.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
1.0 | 79.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
1.0 | 5.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.0 | 5.1 | GO:0030274 | LIM domain binding(GO:0030274) |
1.0 | 4.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.0 | 3.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.0 | 2.0 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.0 | 4.0 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.0 | 7.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.0 | 4.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.0 | 10.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.0 | 2.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.0 | 2.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.0 | 5.8 | GO:0043814 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
1.0 | 3.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.0 | 2.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.0 | 3.8 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.9 | 0.9 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.9 | 0.9 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.9 | 10.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.9 | 10.8 | GO:0035198 | miRNA binding(GO:0035198) |
0.9 | 3.6 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.9 | 4.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.9 | 3.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.9 | 0.9 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.9 | 2.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.9 | 3.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.9 | 0.9 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.9 | 2.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.8 | 5.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.8 | 2.5 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.8 | 3.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.8 | 2.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.8 | 4.9 | GO:0038132 | neuregulin binding(GO:0038132) |
0.8 | 2.4 | GO:0004103 | choline kinase activity(GO:0004103) |
0.8 | 3.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.8 | 0.8 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.8 | 3.2 | GO:0005534 | galactose binding(GO:0005534) |
0.8 | 5.4 | GO:0005113 | patched binding(GO:0005113) |
0.8 | 7.7 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.8 | 3.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.8 | 8.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.8 | 1.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.8 | 2.3 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.8 | 2.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.7 | 2.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.7 | 3.7 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.7 | 2.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.7 | 5.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.7 | 2.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.7 | 2.9 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.7 | 2.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.7 | 9.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.7 | 6.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.7 | 2.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.7 | 0.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.7 | 3.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.7 | 167.8 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.7 | 1.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.7 | 0.7 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.7 | 2.0 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.7 | 1.3 | GO:0070888 | E-box binding(GO:0070888) |
0.7 | 7.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.7 | 3.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.7 | 2.0 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.7 | 2.0 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.7 | 7.8 | GO:0001047 | core promoter binding(GO:0001047) |
0.6 | 2.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.6 | 3.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.6 | 2.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.6 | 1.9 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.6 | 3.7 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.6 | 1.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.6 | 3.0 | GO:0035326 | enhancer binding(GO:0035326) |
0.6 | 0.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.6 | 2.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.6 | 2.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.6 | 1.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.6 | 0.6 | GO:0019956 | chemokine binding(GO:0019956) |
0.6 | 2.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.6 | 1.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.6 | 3.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.6 | 66.1 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.6 | 1.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.6 | 1.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.6 | 3.4 | GO:0048185 | activin binding(GO:0048185) |
0.6 | 0.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.6 | 4.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.6 | 2.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.6 | 2.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.6 | 3.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.5 | 1.6 | GO:0043426 | MRF binding(GO:0043426) |
0.5 | 2.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.5 | 1.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.5 | 0.5 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.5 | 1.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.5 | 3.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.5 | 2.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.5 | 2.6 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.5 | 1.6 | GO:0001032 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.5 | 1.6 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.5 | 1.0 | GO:0050692 | DBD domain binding(GO:0050692) |
0.5 | 4.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.5 | 3.0 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.5 | 1.5 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.5 | 1.0 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.5 | 0.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 201.2 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.5 | 3.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.5 | 1.5 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.5 | 2.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.5 | 2.9 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.5 | 1.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.5 | 6.6 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.5 | 1.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.5 | 2.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.5 | 4.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.5 | 0.5 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.5 | 2.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.5 | 2.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.5 | 1.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.5 | 3.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.5 | 1.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.5 | 1.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.4 | 5.4 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.4 | 1.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.4 | 3.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.4 | 1.3 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.4 | 2.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 1.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 2.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.4 | 1.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.4 | 3.5 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.4 | 2.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.4 | 0.9 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.4 | 1.3 | GO:0051870 | methotrexate binding(GO:0051870) |
0.4 | 0.4 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.4 | 0.9 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 0.4 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.4 | 0.9 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 3.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 2.6 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.4 | 1.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 1.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.4 | 6.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.4 | 1.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.4 | 3.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.4 | 1.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.4 | 3.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.4 | 0.8 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 1.2 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.4 | 1.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.4 | 1.2 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 5.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.4 | 1.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.4 | 2.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.4 | 2.0 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 4.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 3.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 3.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.4 | 2.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.4 | 1.2 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.4 | 1.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 1.5 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.4 | 1.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.4 | 1.9 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.4 | 1.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.4 | 0.8 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.4 | 1.9 | GO:0016936 | galactoside binding(GO:0016936) |
0.4 | 7.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.4 | 0.7 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.4 | 1.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.4 | 2.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.4 | 8.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.4 | 6.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 0.7 | GO:0031014 | troponin T binding(GO:0031014) |
0.4 | 0.7 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.4 | 2.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.4 | 1.8 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.4 | 2.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 1.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.4 | 0.4 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.4 | 2.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.4 | 1.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.4 | 1.4 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.4 | 1.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.3 | 0.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 3.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.3 | 3.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 1.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 2.1 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 1.4 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.3 | 4.7 | GO:0008143 | poly(A) binding(GO:0008143) |
0.3 | 1.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 1.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 3.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.3 | 1.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.3 | 1.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 0.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.3 | 2.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 1.0 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 0.7 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 0.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 0.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 0.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 1.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 6.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 3.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 0.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 1.2 | GO:0043723 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.3 | 1.8 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.3 | 0.9 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.3 | 0.9 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.3 | 1.2 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.3 | 1.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.3 | 5.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 2.0 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.3 | 0.8 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 0.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 5.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 4.5 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 1.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 3.3 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.3 | 2.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.3 | 0.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.3 | 4.4 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 2.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 0.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.3 | 0.5 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.3 | 1.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.3 | 6.7 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.3 | 0.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.3 | 4.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.3 | 1.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.3 | 3.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 0.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 1.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.3 | 2.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 0.8 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 2.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 1.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 0.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 0.8 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.3 | 0.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 1.0 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.2 | 0.7 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 0.7 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 0.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 3.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 6.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 1.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 1.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 0.7 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.2 | 3.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.7 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.9 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 1.2 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 7.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 0.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 1.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 1.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.2 | 24.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 6.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 2.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 1.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.9 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 0.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 0.4 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.2 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 1.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 7.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 0.8 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 1.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 0.6 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 1.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 0.6 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 2.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 0.2 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.2 | 0.8 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 1.4 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.4 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 4.0 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.2 | 0.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 1.1 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.2 | 1.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.2 | 0.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.4 | GO:0035877 | death effector domain binding(GO:0035877) |
0.2 | 1.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 0.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 0.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 2.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 0.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 0.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 2.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 1.5 | GO:0046977 | TAP binding(GO:0046977) |
0.2 | 2.9 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 0.5 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 1.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 0.7 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.2 | 1.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 1.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.7 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 0.5 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 0.3 | GO:0015116 | secondary active sulfate transmembrane transporter activity(GO:0008271) sulfate transmembrane transporter activity(GO:0015116) |
0.2 | 0.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 1.7 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 1.0 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.2 | 0.5 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 6.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 1.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 0.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 0.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.2 | 0.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.2 | 0.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.5 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.2 | 0.2 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.2 | 0.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 4.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 1.4 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.2 | 2.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 2.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 4.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 4.8 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 1.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 0.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 0.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 0.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 1.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.2 | 3.1 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.2 | 1.7 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 2.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 0.9 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 1.8 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.6 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.1 | 0.7 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.4 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 3.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 23.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.6 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 3.3 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.7 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 1.0 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 1.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 1.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.5 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 3.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.6 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 1.0 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 1.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 1.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.9 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.2 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.1 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.1 | 0.4 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 0.7 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.4 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.5 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 2.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.6 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.7 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 21.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.3 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.1 | 0.3 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 3.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 3.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.7 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 1.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 1.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.4 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 1.2 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 1.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 1.1 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.4 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.1 | 3.2 | GO:0018733 | 3,4-dihydrocoumarin hydrolase activity(GO:0018733) |
0.1 | 0.1 | GO:1901677 | phosphate transmembrane transporter activity(GO:1901677) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 2.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.2 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.9 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.5 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.1 | 0.4 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.8 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.1 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.1 | 1.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 1.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.4 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 0.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 1.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 1.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.7 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.4 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.3 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 1.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.6 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 2.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 2.7 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 0.3 | GO:0018450 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 1.9 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.0 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.0 | 0.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 2.3 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 1.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 1.0 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.0 | 0.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.1 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.4 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.2 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.0 | 4.2 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.0 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.0 | 0.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.4 | GO:0019955 | cytokine binding(GO:0019955) |
0.0 | 0.4 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.0 | 0.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.5 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.9 | GO:0061134 | peptidase regulator activity(GO:0061134) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.0 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 1.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.3 | 14.0 | PID ALK2 PATHWAY | ALK2 signaling events |
1.1 | 50.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.1 | 1.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.7 | 8.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.7 | 16.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.7 | 24.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.7 | 49.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.7 | 4.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.7 | 24.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.6 | 24.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.6 | 1.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.6 | 1.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 17.8 | PID BMP PATHWAY | BMP receptor signaling |
0.5 | 10.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.5 | 2.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.5 | 2.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.5 | 14.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.5 | 9.7 | PID EPO PATHWAY | EPO signaling pathway |
0.5 | 7.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.5 | 3.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.5 | 20.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.5 | 5.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.5 | 4.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.5 | 4.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.5 | 1.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.5 | 0.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.5 | 0.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.5 | 4.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 2.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 3.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.4 | 15.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.4 | 4.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.4 | 4.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 5.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.4 | 18.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.4 | 0.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 15.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.4 | 2.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.4 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.4 | 1.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.4 | 7.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 2.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 11.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 0.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 7.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 3.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 10.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.3 | 5.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 1.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 2.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 1.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.3 | 0.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 16.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 9.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 4.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.3 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 4.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 2.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 6.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 1.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 1.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 3.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 4.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 3.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 5.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 0.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 5.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 1.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 3.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 1.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 0.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 2.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 1.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 2.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 1.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 4.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 0.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 3.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 9.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 2.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 2.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 3.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 2.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 2.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 21.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 4.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 17.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.7 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.6 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 4.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 46.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
1.4 | 2.8 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
1.2 | 16.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.0 | 16.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.0 | 24.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.9 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.9 | 2.6 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.7 | 8.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.7 | 5.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.7 | 10.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.7 | 2.8 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.7 | 7.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.7 | 7.9 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.6 | 1.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.6 | 11.4 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.6 | 4.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.6 | 16.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.6 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.6 | 8.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.6 | 2.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.6 | 15.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.5 | 6.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.5 | 9.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.5 | 7.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.5 | 7.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 5.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.5 | 8.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.5 | 8.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.5 | 12.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.5 | 5.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.5 | 23.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.5 | 12.7 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.4 | 8.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 2.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.4 | 41.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.4 | 4.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.4 | 4.7 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.4 | 0.8 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.4 | 8.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 4.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 4.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 4.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 1.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.4 | 4.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.4 | 0.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.4 | 0.4 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.4 | 7.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 1.8 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.4 | 0.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 5.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 1.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 3.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 1.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.3 | 1.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 3.3 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.3 | 3.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 1.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 0.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 4.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.3 | 1.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.3 | 10.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 4.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 9.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 4.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 3.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 2.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 2.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 1.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 3.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.3 | 4.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 5.6 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.3 | 2.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 0.3 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.3 | 0.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.3 | 20.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 4.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 3.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 3.2 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.2 | 2.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 8.0 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.2 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 0.7 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.2 | 1.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 3.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 12.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 0.9 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 2.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 1.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 9.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 1.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 1.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 2.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 2.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 2.6 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 2.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 1.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 1.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 0.6 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.2 | 0.8 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 8.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 6.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 1.8 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 5.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 2.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 0.8 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.2 | 0.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 2.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.2 | 0.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 3.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 2.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 1.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 3.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 4.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.3 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 1.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.2 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 2.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 3.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.6 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.1 | 4.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 4.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 3.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.0 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.8 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 6.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 0.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 3.8 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.7 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 0.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 1.1 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 0.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 3.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 4.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 1.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 2.2 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.9 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.0 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.0 | 0.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.0 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.2 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |